In their study, 25.6% (318 of 1242) of patients with stages I‐III CRC with abnormal preoperative s‐CEA expression, elevated s‐CEA expression was sustained postoperatively, and those with high pre‐ and postoperative s‐CEA expression exhibited poorer outcomes. This evidence concerns the gene CEACAM5 and colorectal carcinoma.